Y-Hl6NAUE90 https://histock.tw/talk/live.aspx?name=gtalk&id=1278 20240529 紫殺

台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國光生

(4142)
可現股當沖
  • 股價
    27.55
  • 漲跌
    ▼0.20
  • 漲幅
    -0.72%
  • 成交量
    427
  • 產業
    上市 生技醫療類股
  • 635人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
國光生 (4142)籌碼相關-富邦-士林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-士林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/11/1000.00332.4532.30-3748-0.40%
2023/11/08232.40232.4032.4507580.00%
2023/10/26131.75231.8331.70-1773-0.13%
2023/10/25131.9500.0031.9517740.13%
2023/09/2000.000.134.5534.60-0.1880-0.01%
2023/09/13033.3000.0033.5508510.00%
2023/09/1100.00232.9333.35-2855-0.23%
2023/09/05132.7500.0032.6518660.12%
2023/09/01133.20133.3533.2008750.00%
2023/08/31133.45133.6033.1508750.00%
2023/08/30133.30133.4533.2008740.00%
2023/08/28232.80132.9532.6518590.12%
2023/08/2500.00133.0533.00-1872-0.11%
2023/08/240.133.20133.3532.80-0.9866-0.10%
2023/08/23132.2500.0032.2018530.12%
2023/08/22332.83233.1332.8018580.12%
2023/08/21233.03233.1032.7008590.00%
2023/08/16232.4500.0032.3028780.23%
2023/08/15433.1600.0033.0548710.46%
2023/08/1400.00133.2033.20-1871-0.11%
2023/08/10333.8500.0033.7538710.34%
2023/07/20136.3500.0036.2019600.10%
2023/07/19537.11536.8036.8009790.00%
2023/07/1300.00236.1335.50-21,009-0.20%
2023/07/10136.40136.5536.4001,0490.00%
2023/07/07136.5500.0036.3511,0590.09%
2023/07/06236.9300.0036.7521,0550.19%
2023/07/05237.1000.0037.1021,0550.19%
2023/07/0400.00237.3537.15-21,067-0.19%
2023/06/2900.00337.6537.45-31,071-0.28%
2023/06/2800.00137.3037.20-11,070-0.09%
2023/06/26837.1700.0037.1081,0820.74%
2023/06/14237.30137.4037.2511,0940.09%
2023/06/09138.4500.0038.4011,1370.09%
2023/06/08138.2500.0038.1511,2040.08%
2023/06/06238.2000.0038.3522,1320.09%
2023/06/05138.3500.0038.3512,1340.05%
2023/05/31138.0500.0038.7512,1630.05%
2023/05/1900.00137.4537.30-12,284-0.04%
2023/05/18137.55137.6037.5002,2890.00%
2023/05/17337.3800.0037.4532,3030.13%
2023/05/1600.00137.6037.30-12,298-0.04%
2023/05/15136.85137.1037.0002,3130.00%
2023/05/12137.3000.0037.5012,3380.04%
2023/05/11138.2000.0037.5512,3700.04%
2023/05/10338.6300.0038.6032,3970.13%
2023/05/09139.8000.0039.0012,5580.04%
2023/05/0200.00340.5740.55-32,923-0.10%
2023/04/26138.7500.0039.1512,9560.03%
2023/04/24140.25141.0040.2502,9360.00%
2023/04/21239.7300.0040.1022,9080.07%
2023/04/1800.00240.7340.75-22,844-0.07%
2023/04/14040.60140.6040.45-12,802-0.04%
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章